The role of accurate testosterone testing in the treatment and management of male hypogonadism

Steroids

Volumn 73, Issue 13, 2008, Pages 1305-1310

  Dobs, Adrian S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Male hypogonadism; Pituitary; Sex hormones; Testis; Testosterone

Indexed keywords

TESTOSTERONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG SAFETY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LABORATORY TEST; MALE; METABOLIC DISORDER; PHYSICAL EXAMINATION; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; KALLMANN SYNDROME; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 54149088220     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.06.007     Document Type: Article

References (27)

1. Ferrini R.L., and Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147 8 (1998) 750-754
2. Kalyani R.R., Gavini S., and Dobs A.S. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 36 June (2) (2007) 333-348 Review. PMID: 17543722
3. Rhoden E.L., and Morgentaler A. N Engl J Med 350 5 (2004) 482-492
4. Selvin E., Feinleib M., Zhang L., et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 30 (2007) 234-238
5. Garaulet G., PeÂrez-Llamas F., Fuente T., et al. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 143 (2000) 657-666
6. Howell S.J., Radford J.A., Ryder W.D., and Shalet S.M. Testicular function after cytotoxic chemotherapy: evidence of leydig cell insufficiency. J Clin Oncol 17 5 (1999) 1493-1498
7. Shafqat A., Einhorn L.H., Hanna N., et al. Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol 16 9 (2005) 1545-1550
8. Shores M., Matsumoto A.M., Sloan K.L., and Kivlahan D.R. Low serum testosterone and mortality in male veterans. Arch Int Med 166 (2006) 1660-1665
9. Laughlin G.A., Barrett-Connor E., and Bergstrom J. Low serum testosterone and mortality in older men. J Endocrinol Metab 93 (2008) 68-75
10. Laaksonen D.E., Niskanen L., Punnonen K., et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27 (2004) 1036-1041
11. Kapoor D., Goodwin E., Channer K.S., and Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154 (2006) 899-906
12. Suttmann U., Ockenga J., Selberg O., Hoogestraat L., Deicher H., and Muller M.J. J Acquir Immune Defic Syndr Hum Retrovirol 8 3 (1995) 239-246
13. Amory J.K., Watts N.B., Easley K.A., et al. Exogenous Testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89 (2004) 503-510
14. Basaria S., Lieb II J., Tang A.M., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56 (2002) 779-786
15. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. J Pain 3 5 (2002) 377-384
16. Dhindsa S., Prabhakar S., Sethi M., et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89 11 (2004) 5462-5468
17. Dobs A.S. Androgen therapy in AIDS wasting. Baillieres Clin Endocrinol Metab 12 3 (1998) 379-390
18. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87 (2002) 589-598
19. Grinspoon S., Corcoran C., Askari H., et al. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129 (1998) 18-26
20. Harman S.M., et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86 2 (2001) 724-731
21. Mohr A., Guay A.T., O'Donnell A.B., and McKinlay J.B. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Aging Study. Clin Endocrinol 62 (2005) 64-73
22. Tenover J.L. Male hormone replacement therapy including andropause. Endocrinol Metabol Clin North Am 27 (1998) 969-987
23. Wang C., Cunningham G., Dobs A.S., et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89 (2004) 2085-2098
24. Woodhouse L.J., Gupta N., Bhasin M., Singh A.B., Ross R., Phillips J., and Bhasin S. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab (2004)
25. Sato N., Katsumata N., Kagami M., et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab 89 3 (2004) 1079-1088
26. Cumming D.C., Quigley M.E., and Yen S.S. Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab 57 3 (1983) 671-673
27. Cameron J.L. Stress and behaviorally induced reproductive dysfunction in primates. Semin Reprod Endocrinol 15 1 (1997) 37-45